We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Medical Image Guidance Systems Developer Reports Demand for Systems in Q1 2016

By HospiMedica International staff writers
Posted on 11 Apr 2016
The developer of an innovative guidance system that can improve the accuracy and clinical outcomes for spine and brain surgery procedures, has announced demand for its systems during the first quarter of 2016.

The technology has been clinically validated, and is being used for surgery and for implants around the world. More...
The company installed four spinal surgery guidance systems in the US, and will install another in Australia. The company has an installed base of 113 Renaissance systems, including a total of 68 systems in the US.

Mazor Robotics (Orlando, FL, USA) develops and manufactures the Renaissance Guidance system. The system uses innovative robotic technology and provides mechanical guidance to help surgeons perform complex procedures. The user interface of the Renaissance system helps surgeons create an accurate surgical blueprint for planning their operation using a virtual 3D environment. The Renaissance system can also reduce the amount of fluoroscopy required for cases of spinal deformity, minimally-invasive surgery, and revision. This can increase the safety of both the patient and the surgeon.

Ori Hadomi, CEO of Mazor Robotics, said, “We’ve had a promising start to 2016 from both system purchase orders and system utilization perspective. We have also developed a robust pipeline for the rest of year. During the first quarter we installed systems at two academic centers in the US, including the Robert Wood Johnson Medical Center New York Metropolitan area, which illustrates our success in penetrating this influential segment of the market. We continue to gain recognition within our target spine surgery market which reflects the clinical and economic benefits which the Renaissance system provides to patients, surgeons and hospitals. As a result of our building momentum we remain confident that we will continue to demonstrate system sales growth in 2016 compared to our all-time record results of 2015.”

Related Links:

Mazor Robotics



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.